Skip to content

Effect of Shool Prashman Dashemani Choorn im Udavartini Yoni Vyapad i.e. Dysmenorrhea or painful menstruation.

Management of udavartini yoni vyapad (dysmenorrhea) with shoolprashmana dashemani & erand bhrusht haritaki, shunthi- a comparative clinical study.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017707
Enrollment
30
Registered
2019-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

Intervention1: Shool Prashman Dashemani Choorn: 5gm orally twice a day before meals with cows ghee followed by luke warm water, for two months Control Intervention1: Erand Bhrusht Haritaki and Shunth

Sponsors

IPGTRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both married and unmarried subjects chief complaint of cramping pain 1day or more prior to the onset of menstruation and during the menstruation along with other symptoms, pain along with scanty or irregular menses, hypothyroidism, PCOS

Exclusion criteria

Exclusion criteria: age less that 18 or more than 30 years, not willing to participate in the study, severe anemia, known case of acid peptic disease, peptic ulcer disease or gastro esophageal reflux, bleeding disorders, uncontrolled diabetes and hypertension, other severe systemic illnesses

Design outcomes

Primary

MeasureTime frame
Decrease in Pain score and menstrual distress symptoms with regularity of mensesTimepoint: Every month at the onset of menstruation, for two consecutive month followed by one month follow up post trial

Secondary

MeasureTime frame
Safety of the drug, improvement in the secondary causes of the dysmenorrhea.Timepoint: 2 months

Countries

India

Contacts

Public ContactProf LP Dei

IPGTRA

deilaxmipriya@yahoo.com9106943729

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026